| Literature DB >> 29168081 |
Hui-Hui Wang1, Peng-Fei Sun1, Wan-Kun Chen1, Jing Zhong1, Qi-Qing Shi2, Mei-Lin Weng1, Duan Ma3, Chang-Hong Miao4.
Abstract
Hyperglycemia is a highly dangerous factor to various diseases, even resulting in death of people. Inflammation plays a key role in this process. The aim of this study was to explore the role of malignant fibrous histiocytoma amplified sequence 1 (MFHAS1) in high-glucose induced inflammation. Our research showed that high glucose stimulated the expression of MFHAS1, and overexpression of MFHAS1 can attenuate high-glucose induced inflammation in endothelial cells by decreasing the secretion of cytokines interleukin-1β (IL-1β), interleukin-1α (IL-1α), adhesion molecule intercellular adhesion molecule-1 (ICAM), interleukin-6 (IL-6), interleukin-8 (IL-8), and chemokine ligand 1 (CXCL-1). Furthermore, we found that MFHAS1 promoted the phosphorylation of Akt and the expression of heme oxygenase-1 (HO-1). Our results indicated that MFHAS1 deadened high-glucose induced inflammation by activating AKT/HO-1 pathway, suggesting that MFHAS1 may act as a new therapeutic target of diabetes mellitus.Entities:
Keywords: AKT; HO-1; MFHAS1; high glucose; inflammation
Mesh:
Substances:
Year: 2018 PMID: 29168081 DOI: 10.1007/s10753-017-0696-0
Source DB: PubMed Journal: Inflammation ISSN: 0360-3997 Impact factor: 4.092